王洪生，教授（主任医师），博士生导师，博士后合作导师。中国医学科学院皮肤病医院（研究所） 麻风分枝杆菌实验室主任。兼任中国麻风防治协会副会长等。获江苏省科技进步二等奖（排名第一）、江苏省六大人才高峰，马海德奖等。近10年来主持了多项国家级和省部级课题；以第一或通讯作者发表110余篇论著，包含New England Journal of Medicine，EBioMedicine.， Emerg Microbes & Infect.等杂志；获得国家发明专利5项。

长期致力于分枝杆菌感染性疾病、银屑病、药物超敏综合征等发病机制、诊断和治疗研究。其领衔的中国医学科学院皮肤病医院分枝杆菌实验室可以承担面向全国的麻风及其他分枝杆菌皮肤感染的临床与实验室诊断和治疗工作，建立了一系列的分枝杆菌皮肤感染的预防、诊疗技术和研究模型，并通过转化应用创建了国际一流的麻风防治的新模式。

中国足球彩票

1. Mei Y#, Zhang W, Shi Y, Jiang H, Zhang Q, Gan T, Peng J, Mei H, Mo S, Wang H*. Mycobacterium camsae sp. nov. and Mycobacterium pumcae sp. nov., two species isolated from human skin infection. Int J Syst Evol Microbiol. 2025 Nov;75(11):006960.(IF=2.0, C0)

2. Jiang Y#, Jiang H, Zou Y, Wang Z, Gan T, Zeng R, Shi Y, Zhang W, Wang H*. Langhans giant cells regulate cutaneous immune responses during mycobacterial infection through CXCL1/CXCL2 secretion. Int Immunopharmacol. 2025 Apr 16;152:114447. (IF=4.7, C0)

3. Wang L#, Wang H*#, Yan L, Yu M, Yang J, Li J, Li J, Ning Y, Jiang H, Shi Y, Zhang W, Xiong L, Liu J, Kuang Y, Wang H, He J, Wang D, Li B, Liu Y, Shui T, Wang Y, Chen H, Sha X, Long H, Yu X, Shen C, Shen J, Yang X, Gu H, Zhang G, Wang B*. Single-Dose Rifapentine in Household Contacts of Patients with Leprosy. N Engl J Med. 2023 May 18;388(20):1843-1852. (IF=96.3, F1000)

4. Wang Z#, Bo H, Cheng C, Gan T, Peng J, Zou Y, Jiang H, Wang H*. Analysis of the efficacy of Langhans giant cells in controlling cutaneous Mycobacterium marinum infections. Int Immunopharmacol. 2025 Feb 20;148:114003.(IF=4.7,C1)

5. Jiang H#, Wang CW#, Wang Z#, Dai Y, Zhu Y, Lee YS, Cao Y, Chung WH*, Ouyang S*, Wang H*. Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity. J Biomed Sci. 2022 Aug 13;29(1):58. (IF=11, C13)

6. Long SY#, Sun JY, Wang L, Long H, Jiang HQ, Shi Y, Zhang WY, Xiong JS, Sun PW, Chen YQ, Mei YM, Pan C, Wang ZZ, Wu ZW, Wu AP, Yu MW*, Wang HS*. Predictive nomogram for leprosy using genetic and epidemiological risk factors in Southwestern China: Case-control and prospective analyses. EBioMedicine. 2021 Jun;68:103408. (IF=11.21, C9)

7. Mei YM#, Zhang Q#, Zhang WY#, Jiang HQ, Shi Y, Xiong JS, Wang L, Chen YQ, Long SY, Pan C, Ge G, Wang ZZ, Wu ZW, Wang Y, Jiang YQ, Wang HS*. Isolation of Novel Mycobacterium Species from Skin Infection in an Immunocompromised Person. Emerg Infect Dis. 2021 Nov;27(11):2944-2947. (IF=16.13, C2)

8. Wang H*#, Jiang H#, Teles RMB#, Chen Y, Wu A, Lu J, Chen Z, Ma F, Pellegrini M, Modlin RL*. Cellular, Molecular, and Immunological Characteristics of Langhans Multinucleated Giant Cells Programmed by IL-15. J Invest Dermatol. 2020 Sep;140(9):1824-1836.e7. (IF=8.551, C10)

9. Chokkakula S#, Chen Z, Wang L, Jiang H, Chen Y, Shi Y, Zhang W, Gao W, Yang J, Li J, Li X, Shui T, He J, Shen L, Liu J, Wang D, Wang H, Chen H, Kuang Y, Li B, Chen Z, Wu A, Yu M, Yan L, Suryadevara NC, Vissa V, Liu W, Wang H*. Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients. Emerg Microbes Infect. 2019;8(1):1479-1489.(IF=6.212, C14)

10. Wang H#, Yan L, Zhang G, Chen X, Yang J, Li M, Shen J, Yu M, Huo R, Wang B*. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China. J Invest Dermatol. 2013 Nov;133(11):2642-2644. (IF=7.216, C100)